Abstract
In this chapter, we review the feeding and energy expenditure effects of orexin (also known as hypocretin) and neuromedin. Orexins are multifunctional neuropeptides that affect energy balance by participating in regulation of appetite, arousal, and spontaneous physical activity. Central orexin signaling for all functions originates in the lateral hypothalamus–perifornical area and is likely functionally differentiated based on site of action and on interacting neural influences. The effect of orexin on feeding is likely related to arousal in some ways but is nonetheless a separate neural process that depends on interactions with other feeding-related neuropeptides. In a pattern distinct from other neuropeptides, orexin stimulates both feeding and energy expenditure. Orexin increases in energy expenditure are mainly by increasing spontaneous physical activity, and this energy expenditure effect is more potent than the effect on feeding. Global orexin manipulations, such as in transgenic models, produce energy balance changes consistent with a dominant energy expenditure effect of orexin. Neuromedins are gut–brain peptides that reduce appetite. There are gut sources of neuromedin, but likely the key appetite-related neuromedin-producing neurons are in the hypothalamus and parallel other key anorectic neuropeptide expression in the arcuate to paraventricular hypothalamic projection. As with other hypothalamic feeding-related peptides, hindbrain sites are likely also important sources and targets of neuromedin anorectic action. Neuromedin increases physical activity in addition to reducing appetite, thus producing a consistent negative energy balance effect. Together with the other various neuropeptides, neurotransmitters, neuromodulators, and neurohormones, neuromedin and orexin act in the appetite network to produce changes in food intake and energy expenditure, which ultimately influences the regulation of body weight.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrahamson EE, Leak RK, Moore RY (2001) The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport 12(2):435–440
Ahnaou A, Drinkenburg WH (2011) Neuromedin U(2) receptor signaling mediates alteration of sleep-wake architecture in rats. Neuropeptides 45(2):165–174
Alvarez CE, Sutcliffe JG (2002) Hypocretin is an early member of the incretin gene family. Neurosci Lett 324(3):169–172
Antunes VR, Brailoiu GC, Kwok EH, Scruggs P, Dun NJ (2001) Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am J Physiol Regul Integr Comp Physiol 281(6):R1801–R1807
Asakawa A, Inui A, Goto K, Yuzuriha H, Takimoto Y, Inui T et al (2002) Effects of agouti-related protein, orexin and melanin-concentrating hormone on oxygen consumption in mice. Int J Mol Med 10(4):523–525
Bader R, Colomb J, Pankratz B, Schrock A, Stocker RF, Pankratz MJ (2007) Genetic dissection of neural circuit anatomy underlying feeding behavior in Drosophila: distinct classes of hugin-expressing neurons. J Comp Neurol 502(5):848–856
Baldo BA, Kelley AE (2001) Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior. Am J Physiol Regul Integr Comp Physiol 281(4):R1232–R1242
Ballesta J, Carlei F, Bishop AE, Steel JH, Gibson SJ, Fahey M et al (1988) Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience 25(3):797–816
Baumann CR, Clark EL, Pedersen NP, Hecht JL, Scammell TE (2008) Do enteric neurons make hypocretin? Regul Pept 147(1–3):1–3
Bergman JM, Roecker AJ, Mercer SP, Bednar RA, Reiss DR, Ransom RW et al (2008) Proline bis-amides as potent dual orexin receptor antagonists. Bioorg Med Chem Lett 18(4):1425–1430
Berthoud HR, Patterson LM, Sutton GM, Morrison C, Zheng H (2005) Orexin inputs to caudal raphe neurons involved in thermal, cardiovascular, and gastrointestinal regulation. Histochem Cell Biol 123(2):147–156
Biello SM, Janik D, Mrosovsky N (1994) Neuropeptide Y and behaviorally induced phase shifts. Neuroscience 62(1):273–279
Blanco M, Lopez M, Garcia-Caballero T, Gallego R, Vazquez-Boquete A, Morel G et al (2001) Cellular localization of orexin receptors in human pituitary. J Clin Endocrinol Metab 86(4):1616–1619
Bourgin P, Huitron-Resendiz S, Spier AD, Fabre V, Morte B, Criado JR et al (2000) Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20(20):7760–7765
Bray GA (2000) Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. Int J Obes Relat Metab Disord 24(Suppl 2):S8–S17
Brighton PJ, Szekeres PG, Willars GB (2004) Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol Rev 56(2):231–248
Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S et al (2007) Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13(2):150–155
Broberger C, De Lecea L, Sutcliffe JG, Hokfelt T (1998) Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402(4):460–474
Campbell RE, Smith MS, Allen SE, Grayson BE, Ffrench-Mullen JM, Grove KL (2003a) Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J Neurosci 23(4):1487–1497
Campbell RE, Grove KL, Smith MS (2003b) Gonadotropin-releasing hormone neurons coexpress orexin 1 receptor immunoreactivity and receive direct contacts by orexin fibers. Endocrinology 144(4):1542–1548
Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C et al (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98(4):437–451
Chen CT, Dun SL, Kwok EH, Dun NJ, Chang JK (1999) Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 260(3):161–164
Chen CT, Hwang LL, Chang JK, Dun NJ (2000) Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am J Physiol Regul Integr Comp Physiol 278(3):R692–R697
Ciriello J, Rosas-Arellano MP, Solano-Flores LP, de Oliveira CV (2003a) Identification of neurons containing orexin-B (hypocretin-2) immunoreactivity in limbic structures. Brain Res 967(1–2):123–131
Ciriello J, Li Z, de Oliveira CV (2003b) Cardioacceleratory responses to hypocretin-1 injections into rostral ventromedial medulla. Brain Res 991(1–2):84–95
Cutler DJ, Morris R, Sheridhar V, Wattam TA, Holmes S, Patel S et al (1999) Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides 20(12):1455–1470
Dall’Aglio C, Pascucci L, Mercati F, Giontella A, Pedini V, Scocco P et al (2008) Identification of orexin A- and orexin type 2 receptor-positive cells in the gastrointestinal tract of neonatal dogs. Eur J Histochem 52(4):229–235
Dall’aglio C, Pascucci L, Mercati F, Giontella A, Pedini V, Ceccarelli P (2009) Immunohistochemical identification and localization of orexin A and orexin type 2 receptor in the horse gastrointestinal tract. Res Vet Sci 86(2):189–193
Dall’aglio C, Pascucci L, Mercati F, Boiti C, Ceccarelli P (2011) Localization of the orexin system in the gastrointestinal tract of fallow deer. Acta Histochem. 2011 March 11 [Epub ahead of print]
Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K et al (1999) Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96(2):748–753
Date Y, Mondal MS, Matsukura S, Nakazato M (2000) Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci Lett 288(2):87–90
de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE et al (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95(1):322–327
de Miguel MJ, Burrell MA (2002) Immunocytochemical detection of orexin A in endocrine cells of the developing mouse gut. J Histochem Cytochem 50(1):63–69
de Oliveira CV, Ciriello J (2003) Cardiovascular responses to hypocretin-1 in nucleus ambiguus of the ovariectomized female rat. Brain Res 986(1–2):148–156
de Oliveira CV, Rosas-Arellano MP, Solano-Flores LP, Ciriello J (2003) Cardiovascular effects of hypocretin-1 in nucleus of the solitary tract. Am J Physiol Heart Circ Physiol 284(4):H1369–H1377
Deurveilher S, Semba K (2005) Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience 130(1):165–183
Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW et al (2009) Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 330(1):142–151
Duxon MS, Stretton J, Starr K, Jones DN, Holland V, Riley G et al (2001) Evidence that orexin-A-evoked grooming in the rat is mediated by orexin- 1 (OX1) receptors, with downstream 5-HT2C receptor involvement. Psychopharmacology (Berl) 153(2):203–209
Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, Bloom SR (1999) The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 160(3):R7–R12
Egecioglu E, Ploj K, Xu X, Bjursell M, Salome N, Andersson N et al (2009) Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice. Am J Physiol Endocrinol Metab 297(3):E708–E716
Ehrstrom M, Gustafsson T, Finn A, Kirchgessner A, Gryback P, Jacobsson H et al (2005) Inhibitory effect of exogenous orexin A on gastric emptying, plasma leptin and the distribution of orexin and orexin receptors in the gut and pancreas in man. J Clin Endocrinol Metab 90(4):2370–2377
Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J et al (1998) Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402(4):442–459
España RA, Baldo BA, Kelley AE, Berridge CW (2001) Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 106(4):699–715
España RA, Valentino RJ, Berridge CW (2003) Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 121(1):201–217
Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M et al (2001) Fos expression in orexin neurons varies with behavioral state. J Neurosci 21(5):1656–1662
Farrell WJ, Delville Y, Wilczynski W (2003) Immunocytochemical localization of orexin in the brain of the green anole lizard (Anolis carolinensis). Soc Neurosci Abs 33:828
Ferguson AV, Samson WK (2003) The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 24(3):141–150
Fu LY, Acuna-Goycolea C, van den Pol AN (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24(40):8741–8751
Fukue Y, Sato T, Teranishi H, Hanada R, Takahashi T, Nakashima Y et al (2006) Regulation of gonadotropin secretion and puberty onset by neuromedin U. FEBS Lett 580(14):3485–3488
Funato H, Tsai AL, Willie JT, Kisanuki Y, Williams SC, Sakurai T et al (2009) Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab 9(1):64–76, PMCID: 2630400
Gartlon J, Szekeres P, Pullen M, Sarau HM, Aiyar N, Shabon U et al (2004) Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology (Berl) 177(1–2):1–14
Gautvik KM, de Lecea L, Gautvik VT, Danielson PE, Tranque P, Dopazo A et al (1996) Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc Natl Acad Sci USA 93(16):8733–8738
Graham ES, Turnbull Y, Fotheringham P, Nilaweera K, Mercer JG, Morgan PJ et al (2003) Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status. J Neurochem 87(5):1165–1173
Guan XM, Yu H, Jiang Q, Van Der Ploeg LH, Liu Q (2001) Distribution of neuromedin U receptor subtype 2 mRNA in the rat brain. Brain Res Gene Expr Patterns 1(1):1–4
Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S et al (1999) Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96(19):10911–10916
Hainerova I, Torekov SS, Ek J, Finkova M, Borch-Johnsen K, Jorgensen T et al (2006) Association between neuromedin U gene variants and overweight and obesity. J Clin Endocrinol Metab 91(12):5057–5063
Hanada R, Nakazato M, Murakami N, Sakihara S, Yoshimatsu H, Toshinai K et al (2001) A role for neuromedin U in stress response. Biochem Biophys Res Commun 289(1):225–228
Hanada T, Date Y, Shimbara T, Sakihara S, Murakami N, Hayashi Y et al (2003) Central actions of neuromedin U via corticotropin-releasing hormone. Biochem Biophys Res Commun 311(4):954–958
Hanada R, Teranishi H, Pearson JT, Kurokawa M, Hosoda H, Fukushima N et al (2004) Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med 10(10):1067–1073
Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM et al (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30(2):345–354
Harrington ME (1997) The ventral lateral geniculate nucleus and the intergeniculate leaflet: interrelated structures in the visual and circadian systems. Neurosci Biobehav Rev 21(5):705–727
Harrington ME, Nance DM, Rusak B (1987) Double-labeling of neuropeptide Y-immunoreactive neurons which project from the geniculate to the suprachiasmatic nuclei. Brain Res 410(2):275–282
Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M et al (1999) Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 20(9):1099–1105
Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, Porter RA et al (2000) A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept 96(1–2):45–51
Hirota K, Kushikata T, Kudo M, Kudo T, Lambert DG, Matsuki A (2001) Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br J Pharmacol 134(7):1461–1466
Hirota K, Kushikata T, Kudo M, Kudo T, Smart D, Matsuki A (2003) Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Res 981(1–2):143–150
Hoch M, Hoever P, Haschke M, Krahenbuhl S, Dingemanse J (2011) Food effect and biocomparison of two formulations of the dual orexin receptor antagonist almorexant in healthy male subjects. J Clin Pharmacol 51(7):1116–1121
Hoever P, de Haas S, Winkler J, Schoemaker RC, Chiossi E, van Gerven J et al (2010) Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant. Clin Pharmacol Ther 87(5):593–600
Honda Y, Doi Y, Ninomiya R, Ninomiya C (1986) Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. Sleep 9(1):254–259
Honzawa M, Sudoh T, Minamino N, Tohyama M, Matsuo H (1987) Topographic localization of neuromedin U-like structures in the rat brain: an immunohistochemical study. Neuroscience 23(3):1103–1122
Honzawa M, Sudoh T, Minamino N, Kangawa K, Matsuo H (1990) Neuromedin U-like immunoreactivity in rat intestine: regional distribution and immunohistochemical study. Neuropeptides 15(1):1–9
Horvath TL (2005) The hardship of obesity: a soft-wired hypothalamus. Nat Neurosci 8(5):561–565
Horvath TL, Diano S, van den Pol AN (1999a) Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 19(3):1072–1087
Horvath TL, Peyron C, Diano S, Ivanov A, Aston-Jones G, Kilduff TS et al (1999b) Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 415(2):145–159
Howard AD, Wang R, Pong SS, Mellin TN, Strack A, Guan XM et al (2000) Identification of receptors for neuromedin U and its role in feeding. Nature 406(6791):70–74
Huesa G, van den Pol AN, Finger TE (2005) Differential distribution of hypocretin (orexin) and melanin-concentrating hormone in the goldfish brain. J Comp Neurol 488(4):476–491
Huhman KL, Albers HE (1994) Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness. Peptides 15(8):1475–1478
Hungs M, Mignot E (2001) Hypocretin/orexin, sleep and narcolepsy. Bioessays 23(5):397–408
Hungs M, Fan J, Lin L, Lin X, Maki RA, Mignot E (2001) Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res 11(4):531–539
Ida T, Nakahara K, Katayama T, Murakami N, Nakazato M (1999) Effect of lateral cerebroventricular injection of the appetite- stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 821(2):526–529
Ida T, Nakahara K, Kuroiwa T, Fukui K, Nakazato M, Murakami T et al (2000a) Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neurosci Lett 293(2):119–122
Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N (2000b) Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270(1):318–323
Iqbal J, Pompolo S, Sakurai T, Clarke IJ (2001) Evidence that orexin-containing neurones provide direct input to gonadotropin-releasing hormone neurones in the ovine hypothalamus. J Neuroendocrinol 13(12):1033–1041
Ivanov TR, Lawrence CB, Stanley PJ, Luckman SM (2002) Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143(10):3813–3821
Ivanov TR, Le Rouzic P, Stanley PJ, Ling WY, Parello R, Luckman SM (2004) Neuromedin U neurones in the rat nucleus of the tractus solitarius are catecholaminergic and respond to peripheral cholecystokinin. J Neuroendocrinol 16(7):612–619
Iwai T, Iinuma Y, Kodani R, Oka J (2008) Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents. Neurosci Res 61(1):113–119
Janik D, Mikkelsen JD, Mrosovsky N (1995) Cellular colocalization of Fos and neuropeptide Y in the intergeniculate leaflet after nonphotic phase-shifting events. Brain Res 698(1–2):137–145
Jaszberenyi M, Bagosi Z, Thurzo B, Foldesi I, Telegdy G (2007) Endocrine and behavioral effects of neuromedin S. Horm Behav 52(5):631–639
Jászberényi M, Bujdosó E, Pataki I, Telegdy G (2000) Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 12(12):1174–1178
Jethwa PH, Small CJ, Smith KL, Seth A, Darch SJ, Abbott CR et al (2005) Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. Am J Physiol Endocrinol Metab 289(2):E301–E305
Jethwa PH, Smith KL, Small CJ, Abbott CR, Darch SJ, Murphy KG et al (2006) Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. Endocrinology 147(6):2886–2892
John J, Wu MF, Siegel JM (2000) Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Res Online 3(1):23–28
Johnson RF, Moore RY, Morin LP (1989) Lateral geniculate lesions alter circadian activity rhythms in the hamster. Brain Res Bull 22(2):411–422
Johren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P (2001) Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142(8):3324–3331
Jones DN, Gartlon J, Parker F, Taylor SG, Routledge C, Hemmati P et al (2001) Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology (Berl) 153(2):210–218
Kamisoyama H, Honda K, Saneyasu T, Sugahara K, Hasegawa S (2007) Central administration of neuromedin U suppresses food intake in chicks. Neurosci Lett 420(1):1–5
Kaslin J, Nystedt JM, Ostergard M, Peitsaro N, Panula P (2004) The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems. J Neurosci 24(11):2678–2689
Kirchgessner AL, Liu M (1999) Orexin synthesis and response in the gut. Neuron 24(4):941–951
Kiwaki K, Kotz CM, Wang C, Lanningham-Foster L, Levine JA (2004) Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 286(4):E551–E559
Kiyashchenko LI, Mileykovskiy BY, Lai YY, Siegel JM (2001) Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. J Neurophysiol 85(5):2008–2016
Kotz CM (2006) Integration of feeding and spontaneous physical activity: role for orexin. Physiol Behav 88(3):294–301
Kotz CM, Glass MJ, Levine AS, Billington CJ (2000) Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding. Am J Physiol Regul Integr Comp Physiol 278(2):R499–R503
Kotz CM, Teske JA, Levine JA, Wang C (2002) Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 104(1–3):27–32
Kotz CM, Wang C, Teske JA, Thorpe AJ, Novak CM, Kiwaki K et al (2006) Orexin A mediation of time spent moving in rats: neural mechanisms. Neuroscience 142(1):29–36
Kotz CM, Teske JA, Billington CJ (2008) Neuroregulation of nonexercise activity thermogenesis and obesity resistance. Am J Physiol Regul Integr Comp Physiol 294(3):R699–R710
Kowalski TJ, Spar BD, Markowitz L, Maguire M, Golovko A, Yang S et al (2005) Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. J Endocrinol 185(1):151–164
Kummer M, Neidert SJ, Johren O, Dominiak P (2001) Orexin (hypocretin) gene expression in rat ependymal cells. Neuroreport 12(10):2117–2120
Kunii K, Yamanaka A, Nambu T, Matsuzaki I, Goto K, Sakurai T (1999) Orexins/hypocretins regulate drinking behaviour. Brain Res 842(1):256–261
Langmead CJ, Jerman JC, Brough SJ, Scott C, Porter RA, Herdon HJ (2004) Characterisation of the binding of [3 H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br J Pharmacol 141(2):340–346, PMCID: 1574197
Li A, Nattie E (2010) Antagonism of rat orexin receptors by almorexant attenuates central chemoreception in wakefulness in the active period of the diurnal cycle. J Physiol 588(Pt 15):2935–2944, PMCID: 2956908
Li Y, Li S, Sui N, Kirouac GJ (2009) Orexin-A acts on the paraventricular nucleus of the midline thalamus to inhibit locomotor activity in rats. Pharmacol Biochemand Behav 93(4):506–514
Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X et al (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3):365–376
Liu JJ, Payza K, Huang J, Liu R, Chen T, Coupal M et al (2009) Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2. J Pharmacol Exp Ther 330(1):268–275
Lu XY, Bagnol D, Burke S, Akil H, Watson SJ (2000) Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 37(4):335–344
Lubkin M, Stricker-Krongrad A (1998) Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 253(2):241–245
Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E et al (2009) Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor. Br J Pharmacol 156(8):1326–1341
Mangold C, Ksiazek I, Yun SW, Berger E, Binkert C (2008) Distribution of neuromedin U binding sites in the rat CNS revealed by in vitro receptor autoradiography. Neuropeptides 42(4):377–386
Martinez GS, Smale L, Nuñez AA (2002) Diurnal and nocturnal rodents show rhythms in orexinergic neurons. Brain Res 955(1–2):1–7
Maruyama K, Konno N, Ishiguro K, Wakasugi T, Uchiyama M, Shioda S et al (2008) Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity. J Neuroendocrinol 20(1):71–78
Maruyama K, Kaiya H, Miyazato M, Konno N, Wakasugi T, Uchiyama M et al (2011) Isolation and characterisation of two cDNAs encoding the neuromedin U receptor from goldfish brain. J Neuroendocrinol 23(3):282–291
Matsumura K, Tsuchihashi T, Abe I (2001) Central orexin-A augments sympathoadrenal outflow in conscious rabbits. Hypertension 37(6):1382–1387
Matsuzaki I, Sakurai T, Kunii K, Nakamura T, Yanagisawa M, Goto K (2002) Involvement of the serotonergic system in orexin-induced behavioral alterations in rats. Regul Pept 104(1–3):119–123
McGranaghan PA, Piggins HD (2001) Orexin A-like immunoreactivity in the hypothalamus and thalamus of the Syrian hamster (Mesocricetus auratus) and Siberian hamster (Phodopus sungorus), with special reference to circadian structures. Brain Res 904(2):234–244
Meister B (2000) Control of food intake via leptin receptors in the hypothalamus. Vitam Horm 59:265–304
Methippara MM, Alam MN, Szymusiak R, McGinty D (2000) Effects of lateral preoptic area application of orexin-A on sleep- wakefulness. Neuroreport 11(16):3423–3426
Mileykovskiy BY, Kiyashchenko LI, Siegel JM (2002) Muscle tone facilitation and inhibition after orexin-a (hypocretin-1) microinjections into the medial medulla. J Neurophysiol 87(5):2480–2489
Minamino N, Kangawa K, Matsuo H (1985a) Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem Biophys Res Commun 130(3):1078–1085
Minamino N, Sudoh T, Kangawa K, Matsuo H (1985b) Neuromedins: novel smooth-muscle stimulating peptides identified in porcine spinal cord. Peptides 6(Suppl 3):245–248
Mintz EM, van den Pol AN, Casano AA, Albers HE (2001) Distribution of hypocretin-(orexin) immunoreactivity in the central nervous system of Syrian hamsters (Mesocricetus auratus). J Chem Neuroanat 21(3):225–238
Mitchell JD, Maguire JJ, Davenport AP (2009) Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Br J Pharmacol 158(1):87–103, PMCID: 2795236
Miyazato M, Mori K, Ida T, Kojima M, Murakami N, Kangawa K (2008) Identification and functional analysis of a novel ligand for G protein-coupled receptor, Neuromedin S. Regul Pept 145(1–3):37–41
Monda M, Viggiano A, Mondola P, De Luca V (2001) Inhibition of prostaglandin synthesis reduces hyperthermic reactions induced by hypocretin-1/orexin A. Brain Res 909(1–2):68–74
Monda M, Viggiano A, De Luca V (2003) Paradoxical [correction of parodoxical] effect of orexin A: hypophagia induced by hyperthermia. Brain Res 961(2):220–228
Monda M, Viggiano AN, Viggiano AL, Fuccio F, De Luca V (2004a) Cortical spreading depression blocks the hyperthermic reaction induced by orexin A. Neuroscience 123(2):567–574
Monda M, Viggiano A, Viggiano A, Fuccio F, De Luca V (2004b) Injection of orexin A into the diagonal band of Broca induces sympathetic and hyperthermic reactions. Brain Res 1018(2):265–271
Mondal MS, Nakazato M, Date Y, Murakami N, Yanagisawa M, Matsukura S (1999) Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem Biophys Res Commun 256(3):495–499
Moore RY, Card JP (1994) Intergeniculate leaflet: an anatomically and functionally distinct subdivision of the lateral geniculate complex. J Comp Neurol 344(3):403–430
Moore RY, Abrahamson EA, Van Den Pol A (2001) The hypocretin neuron system: an arousal system in the human brain. Arch Ital Biol 139(3):195–205
Mori K, Miyazato M, Kangawa K (2008) Neuromedin S: discovery and functions. Results Probl Cell Differ 46:201–212
Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, Goto K (1999) Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci Lett 264(1–3):101–104
Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M et al (2000) Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res 873(1):181–187
Nakazato M, Hanada R, Murakami N, Date Y, Mondal MS, Kojima M et al (2000) Central effects of neuromedin U in the regulation of energy homeostasis. Biochem Biophys Res Commun 277(1):191–194
Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K (1999) Distribution of orexin neurons in the adult rat brain. Brain Res 827(1–2):243–260
Nevsimalova S, Vankova J, Stepanova I, Seemanova E, Mignot E, Nishino S (2005) Hypocretin deficiency in Prader-Willi syndrome. Eur J Neurol 12(1):70–72
Niimi M, Sato M, Taminato T (2001a) Neuropeptide Y in central control of feeding and interactions with orexin and leptin. Endocrine 14(2):269–273
Niimi M, Murao K, Taminato T (2001b) Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem. Endocrine 16(3):201–206
Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355(9197):39–40
Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J et al (2001) Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50(3):381–388
Nixon JP, Smale L (2004) Individual differences in wheel-running rhythms are related to temporal and spatial patterns of activation of orexin A and B cells in a diurnal rodent (Arvicanthis niloticus). Neuroscience 127(1):25–34
Nixon JP, Smale L (2005) Orexin fibers form appositions with Fos expressing neuropeptide-Y cells in the grass rat intergeniculate leaflet. Brain Res 1053(1–2):33–37
Nixon JP, Smale L (2007) A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behav Brain Funct 3:28, PMCID: 1913054
Nogueiras R, Tovar S, Mitchell SE, Barrett P, Rayner DV, Dieguez C et al (2006) Negative energy balance and leptin regulate neuromedin-U expression in the rat pars tuberalis. J Endocrinol 190(2):545–553
Novak CM, Levine JA (2007) Central neural and endocrine mechanisms of non-exercise activity thermogenesis and their potential impact on obesity. J Neuroendocrinol 19(12):923–940
Novak CM, Levine JA (2009) Daily intraparaventricular orexin-A treatment induces weight loss in rats. Obesity (Silver Spring) 7(8):1493–1498
Novak CM, Kotz CM, Levine JA (2006a) Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet-resistant rats. Am J Physiol Endocrinol Metab 290(2):E396–E403
Novak CM, Zhang M, Levine JA (2006b) Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis. J Neuroendocrinol 18(8):594–601
Novak CM, Zhang M, Levine JA (2007) Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity. Brain Res 1169:57–68
Novak CM, Escande C, Burghardt PR, Zhang M, Barbosa MT, Chini EN et al (2010) Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity. Horm Behav 58(3):355–367, PMCID: 2923555
Nunez A, Rodrigo-Angulo ML, Andres ID, Garzon M (2009) Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis. Curr Neuropharmacol 7(1):50–59, PMCID: 2724663
Ohkubo T, Boswell T, Lumineau S (2002) Molecular cloning of chicken prepro-orexin cDNA and preferential expression in the chicken hypothalamus. Biochim Biophys Acta 1577(3):476–480
Overeem S, Mignot E, Gert van Dijk J, Lammers GJ (2001) Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 18(2):78–105
Peever JH, Lai YY, Siegel JM (2003) Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 89(5):2591–2600
Peier A, Kosinski J, Cox-York K, Qian Y, Desai K, Feng Y et al (2009) The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2). Endocrinology 150(7):3101–3109, PMCID: 2703546
Perrey DA, Gilmour BP, Runyon SP, Thomas BF, Zhang Y (2011) Diaryl urea analogues of SB-334867 as orexin-1 receptor antagonists. Bioorg Med Chem Lett 21(10):2980–2985, PMCID: 3085582
Petersén Å, Gil J, Maat-Schieman ML, Björkqvist M, Tanila H, Araújo IM et al (2005) Orexin loss in Huntington’s disease. Hum Mol Genet 14(1):39–47
Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG et al (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18(23):9996–10015
Piper DC, Upton N, Smith MI, Hunter AJ (2000) The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 12(2):726–730
Qiu DL, Chu CP, Shirasaka T, Nabekura T, Kunitake T, Kato K et al (2003) Neuromedin U depolarizes rat hypothalamic paraventricular nucleus neurons in vitro by enhancing IH channel activity. J Neurophysiol 90(2):843–850
Qiu DL, Chu CP, Tsukino H, Shirasaka T, Nakao H, Kato K et al (2005) Neuromedin U receptor-2 mRNA and HCN channels mRNA expression in NMU-sensitive neurons in rat hypothalamic paraventricular nucleus. Neurosci Lett 374(1):69–72
Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ et al (1996) A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380(6571):243–247
Raddatz R, Wilson AE, Artymyshyn R, Bonini JA, Borowsky B, Boteju LW et al (2000) Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J Biol Chem 275(42):32452–32459
Rauch M, Riediger T, Schmid HA, Simon E (2000) Orexin A activates leptin-responsive neurons in the arcuate nucleus. Pflugers Arch 440(5):699–703
Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR et al (2000) Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept 96(1–2):71–84
Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR et al (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13(7):1444–1452
Rucinski M, Ziolkowska A, Neri G, Trejter M, Zemleduch T, Tyczewska M et al (2007) Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat. Int J Mol Med 20(2):255–259
Rusak B, Meijer JH, Harrington ME (1989) Hamster circadian rhythms are phase-shifted by electrical stimulation of the geniculo-hypothalamic tract. Brain Res 493(2):283–291
Russell SH, Small CJ, Kennedy AR, Stanley SA, Seth A, Murphy KG et al (2001) Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology 142(12):5294–5302
Sakamoto T, Mori K, Nakahara K, Miyazato M, Kangawa K, Sameshima H et al (2007) Neuromedin S exerts an antidiuretic action in rats. Biochem Biophys Res Commun 361(2):457–461
Sakamoto T, Mori K, Miyazato M, Kangawa K, Sameshima H, Nakahara K et al (2008) Involvement of neuromedin S in the oxytocin release response to suckling stimulus. Biochem Biophys Res Commun 375(1):49–53
Sakurai T (2003) Orexin: a link between energy homeostasis and adaptive behaviour. Curr Opin Clin Nutr Metab Care 6(4):353–360
Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H et al (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92(4):573–585
Sakurai T, Moriguchi T, Furuya K, Kajiwara N, Nakamura T, Yanagisawa M et al (1999) Structure and function of human prepro-orexin gene. J Biol Rhythms 274(25):17771–17776
Samson WK, Gosnell B, Chang JK, Resch ZT, Murphy TC (1999) Cardiovascular regulatory actions of the hypocretins in brain. Brain Res 831(1–2):248–253
Samson WK, Taylor MM, Ferguson AV (2005) Non-sleep effects of hypocretin/orexin. Sleep Med Rev 9(4):243–252
Samson WK, Bagley SL, Ferguson AV, White MM (2010) Orexin receptor subtype activation and locomotor behaviour in the rat. Acta Physiol (Oxf) 198(3):313–324
Sato S, Hanada R, Kimura A, Abe T, Matsumoto T, Iwasaki M et al (2007) Central control of bone remodeling by neuromedin U. Nat Med 13(10):1234–1240
Sato-Suzuki I, Kita I, Seki Y, Oguri M, Arita H (2002) Cortical arousal induced by microinjection of orexins into the paraventricular nucleus of the rat. Behav Brain Res 128(2):169–177
Scammell TE, Winrow CJ (2011) Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 51:243–266
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404(6778):661–671
Semjonous NM, Smith KL, Parkinson JR, Gunner DJ, Liu YL, Murphy KG et al (2009) Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int J Obes (Lond) 33(7):775–785, PMCID: 2711051
Shan L, Qiao X, Crona JH, Behan J, Wang S, Laz T et al (2000) Identification of a novel neuromedin U receptor subtype expressed in the central nervous system. J Biol Chem 275(50):39482–39486
Shibahara M, Sakurai T, Nambu T, Takenouchi T, Iwaasa H, Egashira SI et al (1999) Structure, tissue distribution, and pharmacological characterization of Xenopus orexins. Peptides 20(10):1169–1176
Shirasaka T, Nakazato M, Matsukura S, Takasaki M, Kannan H (1999) Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol 277(6 Pt 2):R1780–R1785
Shirasaka T, Kunitake T, Takasaki M, Kannan H (2002) Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions. Regul Pept 104(1–3):91–95
Siegel JM (1999) Narcolepsy: a key role for hypocretins (orexins). Cell 98(4):409–412
Singletary KG, Delville Y, Farrell WJ, Wilczynski W (2005) Distribution of orexin/hypocretin immunoreactivity in the nervous system of the green Treefrog, Hyla cinerea. Brain Res 1041(2):231–236
Smale L, McElhinny T, Nixon J, Gubik B, Rose S (2001) Patterns of wheel running are related to Fos expression in neuropeptide- Y-containing neurons in the intergeniculate leaflet of Arvicanthis niloticus. J Biol Rhythms 16(2):163–172
Smart D, Jerman JC, Brough SJ, Rushton SL, Murdock PR, Jewitt F et al (1999) Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR. Br J Pharmacol 128(1):1–3
Smith PM, Connolly BC, Ferguson AV (2002) Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure. Brain Res 950(1–2):261–267
Smith MI, Piper DC, Duxon MS, Upton N (2003) Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat. Neurosci Lett 341(3):256–258
Smith PM, Samson WK, Ferguson AV (2007) Cardiovascular actions of orexin-A in the rat subfornical organ. J Neuroendocrinol 19(1):7–13
Stanley BG, Thomas WJ (1993) Feeding responses to perifornical hypothalamic injection of neuropeptide Y in relation to circadian rhythms of eating behavior. Peptides 14(3):475–481
Stanley BG, Magdalin W, Seirafi A, Thomas WJ, Leibowitz SF (1993) The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s). Brain Res 604(1–2):304–317
Sunter D, Morgan I, Edwards CM, Dakin CL, Murphy KG, Gardiner J et al (2001) Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res 907(1–2):27–34
Sutcliffe JG, de Lecea L (2000) The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 62(2):161–168
Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W (1982) Corticotropin releasing factor produces behavioural activation in rats. Nature 297(5864):331–333
Sweet DC, Levine AS, Billington CJ, Kotz CM (1999) Feeding response to central orexins. Brain Res 821(2):535–538
Szekely M (2006) Orexins, energy balance, temperature, sleep-wake cycle. Am J Physiol Regul Integr Comp Physiol 291(3):R530–R532
Szekely M, Petervari E, Balasko M, Hernadi I, Uzsoki B (2002) Effects of orexins on energy balance and thermoregulation. Regul Pept 104(1–3):47–53
Szekely M, Petervari E, Balasko M (2010) Thermoregulation, energy balance, regulatory peptides: recent developments. Front Biosci (Schol Ed) 2:1009–1046
Tachibana T, Matsuda K, Khan MS, Ueda H, Cline MA (2010a) Feeding and drinking response following central administration of neuromedin S in chicks. Comp Biochem Physiol A Mol Integr Physiol 157(1):63–67
Tachibana T, Matsuda K, Khan SI, Ueda H, Cline MA (2010b) Feeding and drinking response following central administrations of bombesin-like peptides in chicks. Comp Biochem Physiol A Mol Integr Physiol 156(4):394–399
Takenoya F, Hirayama M, Kageyama H, Funahashi H, Kita T, Matsumoto H et al (2005) Neuronal interactions between galanin-like-peptide- and orexin- or melanin-concentrating hormone-containing neurons. Regul Pept 126(1–2):79–83
Tanida M, Satomi J, Shen J, Nagai K (2009) Autonomic and cardiovascular effects of central neuromedin U in rats. Physiol Behav 96(2):282–288
Teske JA, Levine AS, Kuskowski M, Levine JA, Kotz CM (2006) Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 291(4):R889–R899
Teske JA, Billington CJ, Kotz CM (2010) Hypocretin/Orexin and Energy Expenditure. Acta Physiol (Oxf) 198:303–312
Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M et al (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27(3):469–474
Thompson EL, Murphy KG, Todd JF, Martin NM, Small CJ, Ghatei MA et al (2004) Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. Biochem Biophys Res Commun 323(1):65–71
Thorpe AJ, Kotz CM (2005) Orexin A in the nucleus accumbens stimulates feeding and locomotor activity. Brain Res 1050(1–2):156–162
Thorpe AJ, Mullett MA, Wang C, Kotz CM (2003) Peptides that regulate food intake: regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. Am J Physiol Regul Integr Comp Physiol 284(6):R1409–R1417
Tsujino N, Sakurai T (2009) Orexin/Hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 61(2):162–176
van den Pol AN (1999) Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 19(8):3171–3182
van den Pol AN, Gao XB, Obrietan K, Kilduff TS, Belousov AB (1998) Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 18(19):7962–7971
van den Top M, Nolan MF, Lee K, Richardson PJ, Buijs RM, Davies CH et al (2003) Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J Physiol 549(Pt 3):809–821
Verty AN, Allen AM, Oldfield BJ (2010) The endogenous actions of hypothalamic peptides on brown adipose tissue thermogenesis in the rat. Endocrinology 151(9):4236–4246
Volgin DV, Saghir M, Kubin L (2002) Developmental changes in the orexin 2 receptor mRNA in hypoglossal motoneurons. Neuroreport 13(4):433–436
Volkoff H, Peter RE (2000) Effects of CART peptides on food consumption, feeding and associated behaviors in the goldfish, Carassius auratus: actions on neuropeptide Y- and orexin A-induced feeding. Brain Res 887(1):125–133
Wang C, Kotz C (2002) Urocortin in the lateral septal area modulates feeding induced by orexin A in the lateral hypothalamus. Am J Physiol Regul Integr Comp Physiol 283(2):R358–R367
Wang J, Osaka T, Inoue S (2001) Energy expenditure by intracerebroventricular administration of orexin to anesthetized rats. Neurosci Lett 315(1–2):49–52
Wang JB, Murata T, Narita K, Honda K, Higuchi T (2003a) Variation in the expression of orexin and orexin receptors in the rat hypothalamus during the estrous cycle, pregnancy, parturition, and lactation. Endocrine 22(2):127–134
Wang J, Osaka T, Inoue S (2003b) Orexin-A-sensitive site for energy expenditure localized in the arcuate nucleus of the hypothalamus. Brain Res 971(1):128–134
Weaver DR (1998) The suprachiasmatic nucleus: a 25-year retrospective. J Biol Rhythms 13(2):100–112
Webb P, Annis JF, Troutman SJ Jr (1980) Energy balance in man measured by direct and indirect calorimetry. Am J Clin Nutr 33(6):1287–1298
Webb IC, Patton DF, Hamson DK, Mistlberger RE (2008) Neural correlates of arousal-induced circadian clock resetting: hypocretin/orexin and the intergeniculate leaflet. Eur J Neurosci 27(4):828–835
Whitman DB, Cox CD, Breslin MJ, Brashear KM, Schreier JD, Bogusky MJ et al (2009) Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n, n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats. ChemMedChem 4(7):1069–1074
Wickland C, Turek FW (1994) Lesions of the thalamic intergeniculate leaflet block activity-induced phase shifts in the circadian activity rhythm of the golden hamster. Brain Res 660(2):293–300
Winrow CJ, Tanis KQ, Reiss DR, Rigby AM, Uslaner JM, Uebele VN et al (2010) Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology 58(1):185–194
Winrow CJ, Gotter AL, Cox CD, Doran SM, Tannenbaum PL, Breslin MJ et al (2011) Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist. J Neurogenet 25(1–2):52–61
Wren AM, Small CJ, Abbott CR, Jethwa PH, Kennedy AR, Murphy KG et al (2002) Hypothalamic actions of neuromedin U. Endocrinology 143(11):4227–4234
Wu MF, John J, Maidment N, Lam HA, Siegel JM (2002) Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 283(5):R1079–R1086
Yamamoto T, Suzuki H, Uemura H, Yamamoto K, Kikuyama S (2004) Localization of orexin-A-like immunoreactivity in prolactin cells in the bullfrog (Rana catesbeiana) pituitary. Gen Comp Endocrinol 135(2):186–192
Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I et al (2000) Orexin-induced food intake involves neuropeptide Y pathway. Brain Res 859(2):404–409
Yang G, Su J, Yao Y, Lei Z, Zhang G, Li X (2010) The regulatory mechanism of neuromedin S on luteinizing hormone in pigs. Anim Reprod Sci 122(3–4):367–374
Yayou K, Kitagawa S, Ito S, Kasuya E, Sutoh M (2009) Effects of intracerebroventricular administration of neuromedin U or neuromedin S in steers. Gen Comp Endocrinol 163(3):324–328
Yokota M, Ozaki Y, Sakamoto F, Yamada S, Saito J, Fujihara H et al (2004) Fos expression in CRF-containing neurons in the rat paraventricular nucleus after central administration of neuromedin U. Stress 7(2):109–112
Yoshimichi G, Yoshimatsu H, Masaki T, Sakata T (2001) Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) 226(5):468–476
Zeng H, Gragerov A, Hohmann JG, Pavlova MN, Schimpf BA, Xu H et al (2006) Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding. Mol Cell Biol 26(24):9352–9363
Zhang J, Luo P (2002) Orexin B immunoreactive fibers and terminals innervate the sensory and motor neurons of jaw-elevator muscles in the rat. Synapse 44(2):106–110
Zhang W, Fukuda Y, Kuwaki T (2005a) Respiratory and cardiovascular actions of orexin-A in mice. Neurosci Lett 385(2):131–136
Zhang S, Blache D, Vercoe PE, Adam CL, Blackberry MA, Findlay PA et al (2005b) Expression of orexin receptors in the brain and peripheral tissues of the male sheep. Regul Pept 124(1–3):81–87
Zhang Y, Jiang D, Zhang J, Wang F, Jiang X, Tao J (2010) Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons. Cell Signal 22(11):1660–1668
Zheng H, Patterson LM, Berthoud HR (2005) Orexin-A projections to the caudal medulla and orexin-induced c-Fos expression, food intake, and autonomic function. J Comp Neurol 485(2):127–142
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nixon, J.P., Kotz, C.M., Novak, C.M., Billington, C.J., Teske, J.A. (2012). Neuropeptides Controlling Energy Balance: Orexins and Neuromedins. In: Joost, HG. (eds) Appetite Control. Handbook of Experimental Pharmacology, vol 209. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-24716-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-24716-3_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24715-6
Online ISBN: 978-3-642-24716-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)